(Reuters) - The U.S. Food and Drug Administration on Friday approved the use of Medtronic's treatment device in a surgery called renal denervation in patients whose high blood pressure cannot be ...

BOROUGH PARK — AN INNOVATIVE PROCEDURE TO CALM THE NERVOUS SYSTEM AND KIDNEYS was launched at Maimonides Medical Center this week. Maimonides has become the first hospital in Brooklyn to offer the ...

Medtronic and Recor Medical stand to benefit from national Medicare coverage for their new device-based treatments for patients with uncontrolled high blood pressure. Medtronic and Recor have had ...

For some, the COVID-19 pandemic might feel far removed from their current day-to-day lives. But others still grapple with long-term health ramifications. After battling COVID-19, Jimmy Strohmaier was ...

Medtronic has outlined both its current market position and ambitious future at the ongoing J.P. Morgan Healthcare Conference.

TUPELO — High blood pressure, or hypertension, is the top preventable cause of strokes and heart attacks in the United States, according to Dr. Barry Bertolet, an interventional cardiologist at the ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for Medicare ...

Many people control their high blood pressure with medication, but that doesn’t work for some. Baylor Scott & White Heart and Vascular Hospital – Dallas last month began using a recently FDA-approved ...

Please provide your email address to receive an email when new articles are posted on . Two FDA-approved renal denervation systems are now commercially available in the U.S. The devices are approved ...